{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:40:35Z","timestamp":1792100435062,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600239"],"award-info":[{"award-number":["81600239"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Science and Technology Innovation Project from Foshan,Guangdong","award":["FS0AA-KJ218-1301-0006"],"award-info":[{"award-number":["FS0AA-KJ218-1301-0006"]}]},{"name":"The Clinical Research Startup Program of Shunde Hospital,Southern Medical University","award":["CRSP2019001"],"award-info":[{"award-number":["CRSP2019001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bone marrow mesenchymal stem cell (BMSC) transplantation represents a promising therapeutic strategy for ischemic heart disease. However, its effects are hampered by the poor viability of transplanted cells and the hostile microenvironment of the ischemic region. Insulin-like growth factor-1 (IGF-1) is an important paracrine growth factor of BMSC and plays an important role in the properties of BMSC. Here, we investigated whether overexpressing IGF-1 could enhance the BMSC viability, migration, anti-apoptosis, and protective effects of cardiomyocytes, and explore the underlying mechanisms\u2019 focus on the role of the AKT\/secreted frizzled-related protein 2 (SFRP2)\/\u03b2-catenin pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We constructed BMSCs overexpressing insulin-like growth factor-1 (BMSCs-IGF-1) or empty vector (BMSCs-NC) using lentivirus, and evaluated cell survival, proliferation, and migration under normoxic and hypoxic conditions. Co-culture of rat cardiomyoblasts with BMSCs was performed to explore the paracrine effect of BMSCs-IGF-1 for rescuing cardiomyoblasts under hypoxia. Transplantation of BMSCs in acute myocardial infarction rats was used to explore the effect of BMSCs-IGF-1 therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      BMSCs-IGF-1 exhibited a higher cell proliferation rate, migration capacity, and stemness, and were more resistant to apoptosis under hypoxia. Overexpression of IGF-1 upregulated the expression of total and nuclear \u03b2-catenin via the AKT-secreted frizzled-related protein 2 (SFRP2) pathway, which enhanced cell survival. Inhibition of AKT or\n                      <jats:italic>SFRP2<\/jats:italic>\n                      knockdown by siRNA significantly antagonized the effect of IGF-1 and decreased the expression of \u03b2-catenin. The expression of \u03b2-catenin target genes, including cyclin D1 and c-Myc, were accordingly decreased. Moreover, BMSCs-IGF-1 could rescue cardiomyoblasts from hypoxia-induced apoptosis and preserve cell viability under hypoxia. Transplantation of BMSCs-IGF-1 into myocardial infarction rats greatly reduced infarct volume than BMSCs-NC, with significantly greater expression of SFRP2 and \u03b2-catenin.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results suggest that in BMSCs overexpressing IGF-1, SFRP2 is an important mediator for the enhancement of stem cell viability via activating, rather than antagonizing, the Wnt\/\u03b2-catenin pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-019-1544-y","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T11:02:27Z","timestamp":1578567747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway"],"prefix":"10.1186","volume":"11","author":[{"given":"Mingzhuo","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-567X","authenticated-orcid":false,"given":"Yuli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,9]]},"reference":[{"issue":"15","key":"1544_CR1","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1093\/eurheartj\/ehy835","volume":"40","author":"J Wu","year":"2019","unstructured":"Wu J, Hall M, Dondo TB, Wilkinson C, Ludman P, DeBelder M, et al. Association between time of hospitalization with acute myocardial infarction and in-hospital mortality. Eur Heart J. 2019;40(15):1214\u201321.","journal-title":"Eur Heart J"},{"issue":"18","key":"1544_CR2","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMra1716145","volume":"380","author":"HM Blau","year":"2019","unstructured":"Blau HM, Daley GQ. Stem cells in the treatment of disease. N Engl J Med. 2019;380(18):1748\u201360.","journal-title":"N Engl J Med"},{"issue":"1","key":"1544_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/jcb.26169","volume":"119","author":"NH Goradel","year":"2018","unstructured":"Goradel NH, Hour FG, Negahdari B, Malekshahi ZV, Hashemzehi M, Masoudifar A, et al. Stem cell therapy: a new therapeutic option for cardiovascular diseases. J Cell Biochem. 2018;119(1):95\u2013104.","journal-title":"J Cell Biochem"},{"issue":"5","key":"1544_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/cells8050467","volume":"8","author":"Carl Randall Harrell","year":"2019","unstructured":"Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells-Basel. 2019;8(5):467.","journal-title":"Cells"},{"issue":"1","key":"1544_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13287-019-1258-1","volume":"10","author":"M Fan","year":"2019","unstructured":"Fan M, Huang Y, Chen Z, Xia Y, Chen A, Lu D, et al. Efficacy of mesenchymal stem cell therapy in systolic heart failure: a systematic review and meta-analysis. Stem Cell Res Ther. 2019;10(1):150.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"1544_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jtcvs.2007.07.071","volume":"135","author":"X Hu","year":"2008","unstructured":"Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA, et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg. 2008;135(4):799\u2013808.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"1544_CR7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/stem.12","volume":"27","author":"M Gnecchi","year":"2009","unstructured":"Gnecchi M, He H, Melo LG, Noiseaux N, Morello F, de Boer RA, et al. Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells. 2009;27(4):971\u20139.","journal-title":"Stem Cells"},{"issue":"49","key":"1544_CR8","doi-asserted-by":"publisher","first-page":"21110","DOI":"10.1073\/pnas.1004708107","volume":"107","author":"W He","year":"2010","unstructured":"He W, Zhang L, Ni A, Zhang Z, Mirotsou M, Mao L, et al. Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction. Proc Natl Acad Sci U S A. 2010;107(49):21110\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1544_CR9","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1152\/physrev.00019.2015","volume":"96","author":"S Golpanian","year":"2016","unstructured":"Golpanian S, Wolf A, Hatzistergos KE, Hare JM. Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue. Physiol Rev. 2016;96(3):1127\u201368.","journal-title":"Physiol Rev"},{"issue":"1","key":"1544_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13287-019-1223-z","volume":"10","author":"KJ Allahdadi","year":"2019","unstructured":"Allahdadi KJ, de Santana TA, Santos GC, Azevedo CM, Mota RA, Nonaka CK, et al. IGF-1 overexpression improves mesenchymal stem cell survival and promotes neurological recovery after spinal cord injury. Stem Cell Res Ther. 2019;10(1):146.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"1544_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3109\/14653249.2011.651531","volume":"14","author":"YL Huang","year":"2012","unstructured":"Huang YL, Kuang J, Hu YZ, Song YB, Qiu RF, Mai WY. Bone marrow stromal cell transplantation combined with angiotensin-converting enzyme inhibitor treatment in rat with acute myocardial infarction and the role of insulin-like growth factor-1. Cytotherapy. 2012;14(5):563\u20139.","journal-title":"Cytotherapy."},{"issue":"1","key":"1544_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1631\/jzus.B1100117","volume":"13","author":"YL Huang","year":"2012","unstructured":"Huang YL, Qiu RF, Mai WY, Kuang J, Cai XY, Dong YG, et al. Effects of insulin-like growth factor-1 on the properties of mesenchymal stem cells in vitro. J Zhejiang Univ Sci B. 2012;13(1):20\u20138.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"7653","key":"1544_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nature22306","volume":"545","author":"CY Janda","year":"2017","unstructured":"Janda CY, Dang LT, You C, Chang J, de Lau W, Zhong ZA, et al. Surrogate Wnt agonists that phenocopy canonical Wnt and beta-catenin signalling. Nature. 2017;545(7653):234\u20137.","journal-title":"Nature."},{"issue":"1","key":"1544_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13287-019-1286-x","volume":"10","author":"K Hang","year":"2019","unstructured":"Hang K, Ye C, Xu J, Chen E, Wang C, Zhang W, et al. Apelin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly through Wnt\/beta-catenin signaling pathway. Stem Cell Res Ther. 2019;10(1):189.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"1544_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.pharep.2017.01.001","volume":"69","author":"Y Liu","year":"2017","unstructured":"Liu Y, Zhou Q, Zhou D, Huang C, Meng X, Li J. Secreted frizzled-related protein 2-mediated cancer events: friend or foe? Pharmacol Rep. 2017;69(3):403\u20138.","journal-title":"Pharmacol Rep"},{"issue":"2","key":"1544_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00441-016-2396-8","volume":"365","author":"T Hasebe","year":"2016","unstructured":"Hasebe T, Fujimoto K, Kajita M, Ishizuya-Oka A. Thyroid hormone activates Wnt\/beta-catenin signaling involved in adult epithelial development during intestinal remodeling in Xenopus laevis. Cell Tissue Res. 2016;365(2):309\u201318.","journal-title":"Cell Tissue Res"},{"issue":"5","key":"1544_CR17","doi-asserted-by":"publisher","first-page":"C710","DOI":"10.1152\/ajpcell.00137.2016","volume":"311","author":"H Lin","year":"2016","unstructured":"Lin H, Angeli M, Chung KJ, Ejimadu C, Rosa AR, Lee T. sFRP2 activates Wnt\/beta-catenin signaling in cardiac fibroblasts: differential roles in cell growth, energy metabolism, and extracellular matrix remodeling. Am J Physiol Cell Physiol. 2016;311(5):C710\u20139.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"1544_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy."},{"issue":"6","key":"1544_CR19","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.stemcr.2016.04.013","volume":"6","author":"P Zhang","year":"2016","unstructured":"Zhang P, Xing C, Rhodes SD, He Y, Deng K, Li Z, et al. Loss of Asxl1 alters self-renewal and cell fate of bone marrow stromal cell, leading to Bohring-Opitz-like syndrome in mice. Stem Cell Rep. 2016;6(6):914\u201325.","journal-title":"Stem Cell Rep"},{"key":"1544_CR20","doi-asserted-by":"publisher","first-page":"369828","DOI":"10.1155\/2015\/369828","volume":"2015","author":"CA Piccinato","year":"2015","unstructured":"Piccinato CA, Sertie AL, Torres N, Ferretti M, Antonioli E. High OCT4 and low p16(INK4A) expressions determine in vitro lifespan of mesenchymal stem cells. Stem Cells Int. 2015;2015:369828.","journal-title":"Stem Cells Int"},{"issue":"5","key":"1544_CR21","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1073\/pnas.0610024104","volume":"104","author":"M Mirotsou","year":"2007","unstructured":"Mirotsou M, Zhang Z, Deb A, Zhang L, Gnecchi M, Noiseux N, et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A. 2007;104(5):1643\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1544_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.yjmcc.2008.11.016","volume":"46","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Deb A, Zhang Z, Pachori A, He W, Guo J, et al. Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a. J Mol Cell Cardiol. 2009;46(3):370\u20137.","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"1544_CR23","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/ijms20040982","volume":"20","author":"Chul Yun","year":"2019","unstructured":"Yun CW, Lee SH. Enhancement of functionality and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for cardiovascular disease. Int J Mol Sci. 2019;20(4):982.","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"1544_CR24","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1002\/jcb.26637","volume":"119","author":"AE Shafei","year":"2018","unstructured":"Shafei AE, Ali MA, Ghanem HG, Shehata AI, Abdelgawad AA, Handal HR, et al. Mechanistic effects of mesenchymal and hematopoietic stem cells: new therapeutic targets in myocardial infarction. J Cell Biochem. 2018;119(7):5274\u201386.","journal-title":"J Cell Biochem"},{"issue":"1","key":"1544_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s13287-017-0695-y","volume":"8","author":"S Roura","year":"2017","unstructured":"Roura S, Galvez-Monton C, Mirabel C, Vives J, Bayes-Genis A. Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario? Stem Cell Res Ther. 2017;8(1):238.","journal-title":"Stem Cell Res Ther"},{"key":"1544_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2121-11-29","volume":"11","author":"A Cselenyak","year":"2010","unstructured":"Cselenyak A, Pankotai E, Horvath EM, Kiss L, Lacza Z. Mesenchymal stem cells rescue cardiomyoblasts from cell death in an in vitro ischemia model via direct cell-to-cell connections. BMC Cell Biol. 2010;11:29.","journal-title":"BMC Cell Biol"},{"key":"1544_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3389\/fphar.2019.00635","volume":"10","author":"AI Abushouk","year":"2019","unstructured":"Abushouk AI, Salem A, Saad A, Afifi AM, Afify AY, Afify H, et al. Mesenchymal stem cell therapy for doxorubicin-induced cardiomyopathy: potential mechanisms, governing factors, and implications of the heart stem cell debate. Front Pharmacol. 2019;10:635.","journal-title":"Front Pharmacol"},{"issue":"5","key":"1544_CR28","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1159\/000494862","volume":"50","author":"X Zeng","year":"2018","unstructured":"Zeng X, Zhang Y, Xu H, Zhang T, Xue Y, An R. Secreted frizzled related protein 2 modulates epithelial-mesenchymal transition and stemness via Wnt\/beta-catenin signaling in choriocarcinoma. Cell Physiol Biochem. 2018;50(5):1815\u201331.","journal-title":"Cell Physiol Biochem"},{"issue":"19","key":"1544_CR29","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1242\/dev.065839","volume":"138","author":"P Esteve","year":"2011","unstructured":"Esteve P, Sandonis A, Ibanez C, Shimono A, Guerrero I, Bovolenta P. Secreted frizzled-related proteins are required for Wnt\/beta-catenin signalling activation in the vertebrate optic cup. Development. 2011;138(19):4179\u201384.","journal-title":"Development."},{"issue":"10","key":"1544_CR30","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/exd.12993","volume":"25","author":"MH Kwack","year":"2016","unstructured":"Kwack MH, Ahn JS, Jang JH, Kim JC, Sung YK, Kim MK. SFRP2 augments Wnt\/beta-catenin signalling in cultured dermal papilla cells. Exp Dermatol. 2016;25(10):813\u20135.","journal-title":"Exp Dermatol"},{"issue":"3","key":"1544_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbrc.2010.08.043","volume":"400","author":"Z von Marschall","year":"2010","unstructured":"von Marschall Z, Fisher LW. Secreted frizzled-related protein-2 (sFRP2) augments canonical Wnt3a-induced signaling. Biochem Biophys Res Commun. 2010;400(3):299\u2013304.","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 6","key":"1544_CR32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1242\/jcs.026096","volume":"121","author":"P Bovolenta","year":"2008","unstructured":"Bovolenta P, Esteve P, Ruiz JM, Cisneros E, Lopez-Rios J. Beyond Wnt inhibition: new functions of secreted frizzled-related proteins in development and disease. J Cell Sci. 2008;121(Pt 6):737\u201346.","journal-title":"J Cell Sci"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1544-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-019-1544-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1544-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T20:07:33Z","timestamp":1610050053000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-019-1544-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,9]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1544"],"URL":"https:\/\/doi.org\/10.1186\/s13287-019-1544-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,9]]},"assertion":[{"value":"13 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the animal experiments were approved by the Shunde Hospital of Southern Medical University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}